IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v44y2021i12d10.1007_s40264-021-01121-8.html
   My bibliography  Save this article

Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season

Author

Listed:
  • Ignacio Salamanca de la Cueva

    (Instituto Hispalense de Pediatría)

  • Elisa Cinconze

    (GSK)

  • Tamara Eckermann

    (Hausarztpraxis Heimeranplatz)

  • Ugo Nwoji

    (GSK)

  • Lode Godderis

    (KU Leuven
    IDEWE)

  • Emily Lu

    (GSK)

  • Xavier Martínez-Gómez

    (Hospital Universitari Vall d’Hebron)

  • Huajun Wang

    (GSK)

  • Emad Yanni

    (GSK)

Abstract

Introduction Seasonal influenza infects millions annually in Europe. Annual influenza vaccination is the most effective measure to reduce the risk of infection and its complications, especially among young children and older adults. Objective We assessed adverse event (AE) frequency after receiving GSK’s inactivated quadrivalent seasonal influenza vaccine (IIV4). Methods A passive enhanced safety surveillance study was conducted in Belgium, Germany, and Spain. Adults who had received GSK's IIV4 or the parent(s)/guardian(s)/legally acceptable representative(s) of children given the vaccine were invited to complete an adverse drug reaction (ADR) card to document AEs experienced within 7 days post vaccination. Results A total of 1082 participants (51.6% females) received GSK's IIV4, including 115 children

Suggested Citation

  • Ignacio Salamanca de la Cueva & Elisa Cinconze & Tamara Eckermann & Ugo Nwoji & Lode Godderis & Emily Lu & Xavier Martínez-Gómez & Huajun Wang & Emad Yanni, 2021. "Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season," Drug Safety, Springer, vol. 44(12), pages 1375-1390, December.
  • Handle: RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01121-8
    DOI: 10.1007/s40264-021-01121-8
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-021-01121-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-021-01121-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01121-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.